Beta2-adrenergic Agonism and Muscle Remodelling

Summary

The study aims to investigate gender-specific adaptations to beta2-adrenoceptor stimulation with selective short- and long-acting beta2-agonist with emphasis on skeletal muscle in relation to performance enhancing effects and anti-doping

Timeline

Start

2018-06-25

Primary completion

2021-05-30

Completion

2021-05-30

Drugs

Indications